Pioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market. Symbol: BIM – ISIN Code: FR0013280286 Reuters: BIOX.PA/Bloomberg: BIM.FP
Enlace externo para bioMérieux
bioMérieux ha compartido esto
🎉 As the year comes to a close, we want to take a moment to thank everyone who has been part of our journey in 2024. To our team members, partners, and customers: your commitment and collaboration continue to drive innovation and positive influence on public health. Wishing you all a joyful holiday season and a successful start to 2025! Let’s continue shaping a healthier future together! Best wishes from bioMérieux! ✨
🎉 As the year comes to a close, we want to take a moment to thank everyone who has been part of our journey in 2024. To our team members, partners, and customers: your commitment and collaboration continue to drive innovation and positive influence on public health. Wishing you all a joyful holiday season and a successful start to 2025! Let’s continue shaping a healthier future together! Best wishes from bioMérieux! ✨
🥣 What if a simple bowl of soup could help change lives? That’s exactly what happens every year with the "Soupe en Scène" charity festival, organized by the association “Envie d’un Sourire”, proudly supported by bioMérieux. Thanks to our partner Eurest France and the incredible Chef Fabrice Bonnot, exclusive soups were served in five of our Rhône-Alpes sites’ restaurants. The result? Over 500 bowls sold, with 100% of the proceeds going to “Envie d’un Sourire” to bring a smile to the faces of the less fortunate. 💕 A huge thanks to our team members, Eurest, and Chef Bonnot for making this initiative a true recipe for solidarity. 👏 #WeArebioMérieux #WeActForAPositiveImpact
bioMérieux ha compartido esto
I’m excited to share the launch of bioMérieux’s new digital campaign to combat #AntimicrobialResistance. 💡 This initiative, developed in collaboration with Pfizer and three patient associations, underscores the critical need for awareness and education on the appropriate use of antibiotics. As Medical Affairs professionals, we have a unique responsibility to bridge the gap between science and clinical practice. By promoting better understanding and stewardship of antimicrobials, we aim to support healthcare providers in their fight against resistant infections and ultimately improve patient outcomes. AMR is a challenge we must tackle together! Read more about our efforts. ⤵️ https://lnkd.in/gvgaZDXg
On November 27th, 2024, bioMérieux in collaboration with the French Embassy in Brazil, hosted a landmark event on the sidelines of the G20 summit and World AMR Week: “Antimicrobial Resistance: How to Change the Game by 2050”. 📝 This conference brought together over 80 participants, including national and international experts to discuss topics such as: - The current state of AMR in Brazil and globally - The impact of AMR on different regions and the disparities in access to diagnostics and antibiotics - New prevention and control strategies, including the role of continuous medical education and public awareness - The importance of diagnostic accessibility and the incorporation of AI in managing health data - The urgent need for updated legislation on the role of hospital pharmacists in AMR programs - The role of international collaboration in implementing lasting solutions to AMR 🗣️ Key speakers included: - Mr. Emmanuel LENAIN, Ambassador of France in Brazil - Mr. Alain MÉRIEUX, President of Institut Mérieux - Dr. Ethel MACIEL, Secretary of Health and Environmental Surveillance of the MoH - Prof. Ramanan LAXMINARAYAN, Founder & President of One Health Trust - Dr. Twisha PATEL, Pharmacist at the National Center of Infectious Diseases, CDC This conference marks the beginning of a multipartite collaboration led by bioMérieux and the French Embassy, aiming to engage the local public health ecosystem through advocacy, training, and policy-shaping in Brazil. #PioneeringDiagnostics
⛵ Early December, we had the pleasure of welcoming Emmanuelle Périé-Bardout, explorer and founder of UNDER THE POLE for an insightful conference at our Ker Lann site in Brittany, France. This event was a great opportunity for our Breton colleagues and team members across France (joining online) to learn about the impactful work UNDER THE POLE is doing to protect our oceans and marine ecosystems. 🌊 By combining scientific research, innovative techniques, and effective awareness-raising, they are making significant strides in ocean preservation. We are proud to have supported this initiative since 2021, aligning with our #CSR commitment to preserve the planet as a healthy place to live. #WeArebioMérieux #WeActForAPositiveImpact
📢 We are announcing today that our BIOFIRE® FILMARRAY® Tropical Fever Panel, a syndromic PCR test targeting causes of tropical fever, has received U.S. Food and Drug Administration (FDA) Special 510(k) clearance. Presentation of tropical fever infections – including malaria, chikungunya or dengue – are often non-specific and overlapping, complicating efforts to distinguish mild self-limiting illness from more severe diseases that require prompt and targeted treatment. The BIOFIRE® FILMARRAY® Tropical Fever (TF) Panel allows healthcare providers to quickly identify pathogens commonly found in patients presenting with suspected tropical fever infections in one fast easy-to-use test. 📰 Read the full press release: https://lnkd.in/eD_-tXue #PioneeringDiagnostics
Antimicrobial Resistance (AMR) isn’t just a healthcare challenge—it’s a societal one. ✍️ In this insightful article, Vanessa Carter, AMR survivor and advocate, highlights the power of patient-centered approaches in driving impactful and sustainable change. Her perspective as both a patient and founder of The AMR Narrative emphasizes why involving communities is essential to tackling AMR effectively. 👉 Read the article: http://spkl.io/6040fZwuA
Today is #InternationalVolunteerDay, an opportunity to celebrate and recognize the contributions of our own volunteers worldwide! 💕 Thanks to the bioMérieux Endowment Fund For Education, our team members have the chance to engage in promoting equal opportunities. Every year, more than 1,000 volunteers participate in one-off missions organized by the Fund. 👏 On top of that, six Regional Coordinators supervise and ensure the efficient coordination of projects, and more than 80 Project Partners (all bioMérieux team members) sponsor the Fund’s initiatives in response to specific local needs and ensure project progress monitoring. #WeArebioMérieux #WeActForAPositiveImpact
Last month, we had the pleasure of hosting five Patient Association Groups at our headquarters for the second edition of the bioMérieux Patient Advisory Board. 🎯 This year's focus was on the critical issue of Antimicrobial Resistance (AMR) and the role that diagnostics could play. Over these two days, we explored the far-reaching impact of AMR—a borderless threat that affects individuals of all ages around the globe. The unique perspectives and lived experiences shared by these patient associations are invaluable in shaping strategies to combat AMR effectively. Our commitment to action is unwavering. The insights, ideas, and best practices exchanged during this Advisory Board will inform our efforts as we strive to bridge gaps and make significant strides in the fight against AMR. 👏 A heartfelt thank you to our esteemed participants: - Guy Bouguet, ELLyE - Ensemble Leucémie Lymphomes Espoir - Jamila Hedjal, France Sepsis Association - Thomas Heymann, Sepsis Alliance - Vanessa Carter, The AMR Narrative - Melissa Head, The UK Sepsis Trust - Dr. Rafael Moraes, ILAS - Instituto Latino Americano de Sepse